Tedisamil attenuates ventricular fibrillation in a conscious canine model of sudden cardiac death

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 1, Issue 4, 1996, Pages 313-324

  Friedrichs, G S ^a   Abreu, J N ^a   Cousins, G R ^a   Chi, L ^a   Borlak, J ^b   Lucchesi, B R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Class III antiarrhythmic; Potassium channel blocker; Sudden death; Tedisamil

Indexed keywords

EID: 0000837747     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/107424849600100407     Document Type: Article

References (31)

1. Lazdunski M. Potassium channels: structure-function relationships, diversity. and pharmacology. Cardiovasc Drugs Ther 6:313, 1992.
2. Escande D, Henry P. Potassium channels as phmacological targets in cardiovascular medicine. Eur Heart J 14: Suppl B2, 1993.
3. Carmeliet E. Potassium channels in cardiac cells. Cardiovasc Drug Ther 6:305, 1992.
4. Lynch JJ, Coskey LA, Montgomery DG, Lucchesi BR. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J 109:949, 1985.
5. Black SC, Chi L, Mu DX, Lucchesi BR. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. J Pharm Exp Ther 258:416, 1991.
6. Black SC, Butterfield JL, Lucchesi BR. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. J Cardiovasc Pharmacol 22:810, 1993.
7. Singh BN. Control of cardiac arrhythmias by prolonging repolarization: historical development of the concept and emerging perspectives. In Singh BN, Wellens HJJ, Hiraoka M (eds). Electropharmacological Control of Cardiac Arrhythmias: To Delay Conduction or to Prolong Refractoriness? Futura Publishing, Mount Kisco, NY, pp 427-440, 1994.
8. Dukes ID, Morad M. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes. Am J Physiol 257:H1746, 1989.
9. Dukes ID, Cleemann L, Morad M. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. J Pharm Exp Ther 254:560, 1990.
10. McLarnon JG, Sawyer D, Michikawa M, Kim SU. Tedisamil blocks a calcium-dependent potassium channel in cultured motoneurons. Neurosci Lett 144:185, 1992.
11. Chi L, Park JL, Friedrichs GS, Banglawala YA, Perez MA, Tanhehco EJ, Lucchesi BR. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart. Br J Pharmacol 117:1261, 1996.
12. Tsuchihashi K, Curtis MJ. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade. J Cardiovasc Pharmacol 18:445, 1991.
13. Adaikan G, Beatch GN, Lee TL, Ratnam SS, Walker MJA. Antiarrhythmic actions of tedisamil: studies in rats and primates. Cardiovasc Drugs Ther 6:345, 1992.
14. Bril A, Landais L, Gout B. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. Cardiovasc Drugs Ther 7:233, 1993.
15. Patterson E, Holland K, Eller BT, Lucchesi BR. Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction: a conscious canine model of suddcn coronary death. Am J Cardiol 50:1414, 1982.
16. Woosley RL. Antiarrhythmic drugs. Annu Rev Pharm Toxicol 31:427, 1991.
17. Ellingboe JW, Spinelli W, Winkey MW,et al.Class III antiarrhythmic activity of novel substituted 4-[(methylsul-fonyl) amino] benzamides and sulfonamides. J Med Chem 35:705, 1992.
18. Takanaka C, Sarma JSM, Singh BN. Electrophysiological effects of ambasilide (LV 47110), a novel class III antiarrhythmic agent, on properties of isolated rabbit and canine cardiac muscle. J Cardiovasc Pharmacol 19:290, 1992.
19. Lynch JJ, DiCarla LA, Montgomery DG, Lucchesi BR. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium. J Cardiovasc Pharmacol 8:957, 1986.
20. Friedrichs GS, Chi L, Gralinski MR,et al.MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death. J Cardiovasc Pharmacol 25:314, 1995.
21. Richards DAB, Byth K, Ross DL, Uther JB. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 83:756, 1991.
22. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406, 1989.
23. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227, 1992.
24. Wallace AA, Stupienski RF, Baskin EP,et al.Cardiac electrophysiologic and antiarrhythmic actions of tedisamil. J Pharm Exp Ther 273:168, 1995.
25. Carlsson L, Almgren O, Duker G. QTU-prolongation and torsade de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J Cardiovasc Pharmacol 16:276, 1990.
26. Myergurg RJ, Kessler KM, Castellanos A. Sudden cardiac death: sturcture, function and time-dependence of risk. Circulation 85:12, 1992.
27. Lynch JJ, DiCarlo LA, Montgomery DG, Lucchesi BR. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. Pharmacology 35:181, 1987.
28. Kou WH, Nelson SD, Lynch JJ, Montgomery DG, DiCarlo L, Lucchesi BR. Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the carly postmyocardial infarction period: evaluation in a conscious canine model of sudden death. J Am Coll Cardiol 9:359, 1987.
29. Beatch GN, MacLeod BA, Abraham S, Walker MJA. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798. Proc West Pharmacol Soc 33:5, 1990.
30. Pfründer D, Kreye VAW. Tedisamil inhibits the delayed rectifier K+ current in single smooth muscle cells of the guinea-pig portal vein. Pflügers Arch 421:22, 1992.
31. Pfründer D, Kreye VAW. Tedisamil blocks single large-conductance Ca+2-activated K+ channels in membrane patches from smooth muscle cells of the guinea-pig portal vein. Pflügers Arch 418:308, 1991.